Safety and Efficacy of Trifluridine-Tipiracil Hydrochloride Oral Combination (TAS-102) in Patients with Unresectable Colorectal Cancer.

导出 OA

翻译打印收藏纠错

作者： Satoshi,Narihiro ^[1] ; Katsuhito,Suwa ^[2] ; Takuro,Ushigome ^[2] ; Masamichi,Ohtsu ^[2] ; Syunjin,Ryu ^[2] ; Yuya,Shimoyama ^[2] ; Tomoyoshi,Okamoto ^[2] ; Katsuhiko,Yanaga ^[3]

作者单位： Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan nasa1355@yahoo.co.jp. ^[1] Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan. ^[2] Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan. ^[3]

关键词 TAS-102 chemotherapy unresectable colorectal carcinoma

主题词投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结直肠肿瘤(Colorectal Neoplasms);无病生存(Disease-Free Survival);复方合剂(Drug Combinations);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);吡咯烷类(Pyrrolidines);胸腺嘧啶(Thymine);治疗结果(Treatment Outcome);曲氟尿苷(Trifluridine);尿嘧啶(Uracil)

DOI 10.21873/invivo.11426

PMID 30348728

发布时间 2020-12-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

In vivo (Athens, Greece)

1643-1646页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and Efficacy of Trifluridine-Tipiracil Hydrochloride Oral Combination (TAS-102) in Patients with Unresectable Colorectal Cancer.

In vivo (Athens, Greece)

相似文献

In vivo (Athens, Greece)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Efficacy of Trifluridine-Tipiracil Hydrochloride Oral Combination (TAS-102) in Patients with Unresectable Colorectal Cancer.

In vivo (Athens, Greece)

相似文献

In vivo (Athens, Greece)

相关期刊

检索历史清除